Aldeyra Therapeutics, Inc.

ALDX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$54,527$142,823$144,419$229,791
Short-Term Investments$46,624$0$29,882$0
Receivables$0$0$3,242$29
Inventory$0$0$0$0
Other Curr. Assets$2,921$4,987$3,480$2,933
Total Curr. Assets$104,072$147,810$181,023$232,753
Property Plant & Equip (Net)$267$517$269$384
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$267$0$0$0
Total NC Assets$534$517$269$384
Other Assets$0$0$0$0
Total Assets$104,607$148,327$181,292$233,137
Liabilities
Payables$180$1,338$134$1,020
Short-Term Debt$303$15,386$1,161$230
Tax Payable$0$0$0$0
Deferred Revenue$6,000$0$0$0
Other Curr. Liab.$12,118$5,536$14,066$10,523
Total Curr. Liab.$18,602$22,260$15,361$11,773
LT Debt$15,000$272$14,923$15,629
Deferred Rev, NC$0$6,000$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$15,000$6,272$14,923$15,629
Other Liabilities$0$0$0$0
Cap. Leases$272$511$249$355
Total Liabilities$33,602$28,532$30,284$27,402
Equity
Pref Stock$0$0$0$0
Common Stock$60$59$59$58
Retained Earnings-$450,111-$394,259-$356,717-$294,692
AOCI$37$0-$104$0
Other Equity$521,018$513,995$507,770$500,369
Total Equity$71,005$119,795$151,008$205,736
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$104,607$148,327$181,292$233,137
Net Debt-$39,224-$127,166-$128,335-$213,932
Aldeyra Therapeutics, Inc. (ALDX) Financial Statements & Key Stats | AlphaPilot